SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54 | -3.6% | 444 | -9.0% | 0.01% | 0.0% |
| Q2 2023 | $56 | -8.2% | 488 | +1.9% | 0.01% | -18.2% |
| Q1 2023 | $61 | +52.5% | 479 | +42.6% | 0.01% | +57.1% |
| Q4 2022 | $40 | -99.9% | 336 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $39,000 | +44.4% | 336 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $27,000 | +3.8% | 336 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $26,000 | -13.3% | 336 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $30,000 | -3.2% | 336 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $31,000 | +19.2% | 336 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $26,000 | -82.8% | 336 | -83.4% | 0.01% | -82.8% |
| Q1 2021 | $151,000 | – | 2,020 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |